These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 28899690)

  • 41. Cytokine expression and specific lymphocyte proliferation in two strains of Cryptosporidium parvum-infected gamma-interferon knockout mice.
    Smith LM; Bonafonte MT; Mead JR
    J Parasitol; 2000 Apr; 86(2):300-7. PubMed ID: 10780549
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Therapy with atovaquone for Cryptosporidium parvum infection in neonatal severe combined immunodeficiency mice.
    Rohlman VC; Kuhls TL; Mosier DA; Crawford DL; Hawkins DR; Abrams VL; Greenfield RA
    J Infect Dis; 1993 Jul; 168(1):258-60. PubMed ID: 8515130
    [No Abstract]   [Full Text] [Related]  

  • 43. Targeting a uniquely nonspecific prenyl synthase with bisphosphonates to combat cryptosporidiosis.
    Artz JD; Dunford JE; Arrowood MJ; Dong A; Chruszcz M; Kavanagh KL; Minor W; Russell RG; Ebetino FH; Oppermann U; Hui R
    Chem Biol; 2008 Dec; 15(12):1296-306. PubMed ID: 19101474
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The effect of ivermectin on Cryptosporidium parvum in experimentally infected rat.
    Zinada NY
    J Egypt Soc Parasitol; 2000 Dec; 30(3):747-52. PubMed ID: 11198372
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Inhibition of Calcium-Dependent Protein Kinase 1 (CDPK1) In Vitro by Pyrazolopyrimidine Derivatives Does Not Correlate with Sensitivity of Cryptosporidium parvum Growth in Cell Culture.
    Kuhlenschmidt TB; Rutaganira FU; Long S; Tang K; Shokat KM; Kuhlenschmidt MS; Sibley LD
    Antimicrob Agents Chemother; 2016 Jan; 60(1):570-9. PubMed ID: 26552986
    [TBL] [Abstract][Full Text] [Related]  

  • 46. New potential therapies for cryptosporidiosis: an analysis of variables affecting drug efficacy.
    Rehg J
    Folia Parasitol (Praha); 1994; 41(1):23-6. PubMed ID: 8050751
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Two Novel Calcium-Dependent Protein Kinase 1 Inhibitors Interfere with Vertical Transmission in Mice Infected with Neospora caninum Tachyzoites.
    Müller J; Aguado-Martínez A; Balmer V; Maly DJ; Fan E; Ortega-Mora LM; Ojo KK; Van Voorhis WC; Hemphill A
    Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28137808
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Treatment with agmatine inhibits Cryptosporidium parvum infection in infant mice.
    Moore D; Waters WR; Wannemuehler MJ; Harp JA
    J Parasitol; 2001 Feb; 87(1):211-3. PubMed ID: 11227893
    [TBL] [Abstract][Full Text] [Related]  

  • 49. In vitro efficacy of bumped kinase inhibitors against Besnoitia besnoiti tachyzoites.
    Jiménez-Meléndez A; Ojo KK; Wallace AM; Smith TR; Hemphill A; Balmer V; Regidor-Cerrillo J; Ortega-Mora LM; Hehl AB; Fan E; Maly DJ; Van Voorhis WC; Álvarez-García G
    Int J Parasitol; 2017 Oct; 47(12):811-821. PubMed ID: 28899692
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of diethyldithiocarbamate on Cryptosporidium parvum infection in immunosuppressed rats.
    Rehg JE
    J Parasitol; 1996 Feb; 82(1):158-62. PubMed ID: 8627487
    [TBL] [Abstract][Full Text] [Related]  

  • 51. In Vitro and In Vivo Effects of the Bumped Kinase Inhibitor 1294 in the Related Cyst-Forming Apicomplexans Toxoplasma gondii and Neospora caninum.
    Winzer P; Müller J; Aguado-Martínez A; Rahman M; Balmer V; Manser V; Ortega-Mora LM; Ojo KK; Fan E; Maly DJ; Van Voorhis WC; Hemphill A
    Antimicrob Agents Chemother; 2015 Oct; 59(10):6361-74. PubMed ID: 26248379
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Inhibition of cryptosporidium parvum in vitro by 9-(alkylthio)acridine derivatives.
    Khalifa L; Rosales MJ; Mascaro C; Karolak-Wojciechowska J; Bsiri N; Brouant P; Barbe J
    Arzneimittelforschung; 2000 Feb; 50(2):163-6. PubMed ID: 10719621
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Extended-spectrum antiprotozoal bumped kinase inhibitors: A review.
    Van Voorhis WC; Doggett JS; Parsons M; Hulverson MA; Choi R; Arnold SLM; Riggs MW; Hemphill A; Howe DK; Mealey RH; Lau AOT; Merritt EA; Maly DJ; Fan E; Ojo KK
    Exp Parasitol; 2017 Sep; 180():71-83. PubMed ID: 28065755
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cryptosporidium parvum-specific mucosal immune response in C57BL/6 neonatal and gamma interferon-deficient mice: role of tumor necrosis factor alpha in protection.
    Lacroix S; Mancassola R; Naciri M; Laurent F
    Infect Immun; 2001 Mar; 69(3):1635-42. PubMed ID: 11179338
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Susceptibility differences to Cryptosporidium parvum infection in two strains of gamma interferon knockout mice.
    Mead JR; You X
    J Parasitol; 1998 Oct; 84(5):1045-8. PubMed ID: 9794653
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Development of particulate drug formulation against C. parvum: Formulation, characterization and in vivo efficacy.
    Blanco-García E; Guerrero-Callejas F; Blanco-Méndez J; Gómez-Couso H; Luzardo-Álvarez A
    Eur J Pharm Sci; 2016 Sep; 92():74-85. PubMed ID: 27381880
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of dehydroepiandrosterone in immunosuppressed adult mice infected with Cryptosporidium parvum.
    Rasmussen KR; Healey MC; Cheng L; Yang S
    J Parasitol; 1995 Jun; 81(3):429-33. PubMed ID: 7776129
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Treatment of acute and chronic Cryptosporidium parvum infections in mice using clarithromycin and 14-OH clarithromycin.
    Cama VA; Marshall MM; Shubitz LF; Ortega YR; Sterling CR
    J Eukaryot Microbiol; 1994; 41(5):25S. PubMed ID: 7804227
    [No Abstract]   [Full Text] [Related]  

  • 59. Feeding activated charcoal from bark containing wood vinegar liquid (nekka-rich) is effective as treatment for cryptosporidiosis in calves.
    Watarai S; Tana ; Koiwa M
    J Dairy Sci; 2008 Apr; 91(4):1458-63. PubMed ID: 18349239
    [TBL] [Abstract][Full Text] [Related]  

  • 60. IL-12 protects immunocompetent and immunodeficient neonatal mice against infection with Cryptosporidium parvum.
    Urban JF; Fayer R; Chen SJ; Gause WC; Gately MK; Finkelman FD
    J Immunol; 1996 Jan; 156(1):263-8. PubMed ID: 8598471
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.